bucladesine has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itano, Y; Kitamura, Y; Nomura, Y | 1 |
| Boss, BD; Spector, DH; Strecker, RE | 1 |
2 other study(ies) available for bucladesine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
1-Methyl-4-phenylpyridinium (MPP+)-induced cell death in PC12 cells: inhibitory effects of several drugs.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Aurintricarboxylic Acid; Bucladesine; Cycloheximide; L-Lactate Dehydrogenase; Nerve Growth Factors; Parkinson Disease, Secondary; PC12 Cells; Potassium; Rats | 1994 |
A model three-dimensional culture system for mammalian dopaminergic precursor cells: application for functional intracerebral transplantation.
Topics: Animals; Brain Tissue Transplantation; Bucladesine; Cell Aggregation; Cell Differentiation; Cells, Cultured; Dopamine; Embryo, Mammalian; Fetal Tissue Transplantation; Humans; Kinetics; Mesencephalon; Neurons; Oxidopamine; Parkinson Disease, Secondary; Swine; Time Factors; Tyrosine 3-Monooxygenase | 1993 |